BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3762545)

  • 1. IgG subclasses in rheumatoid joint disorders.
    Stanworth DR
    Monogr Allergy; 1986; 19():188-97. PubMed ID: 3762545
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
    Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
    J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in rheumatoid factor isotypes and specificities in MRL mice.
    Bond A; Cooke A; Hay FC
    Immunology; 1988 May; 64(1):17-21. PubMed ID: 3384451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance.
    Gupta B; Raghav SK; Agrawal C; Chaturvedi VP; Das RH; Das HR
    J Autoimmun; 2006 Sep; 27(2):125-33. PubMed ID: 16904869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis.
    Robbins DL; Wistar R
    J Rheumatol; 1985 Jun; 12(3):437-43. PubMed ID: 3900391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations.
    Willemze A; Shi J; Mulder M; Stoeken-Rijsbergen G; Drijfhout JW; Huizinga TW; Trouw LA; Toes RE
    Ann Rheum Dis; 2013 Jun; 72(6):1059-63. PubMed ID: 23486413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses.
    Sato Y; Watanabe H; Kogure A; Miyata M; Watanabe K; Nishimaki T; Kasukawa R; Fujita T
    Clin Rheumatol; 1995 Jul; 14(4):425-8. PubMed ID: 7586979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid factors: what's new?
    Westwood OM; Nelson PN; Hay FC
    Rheumatology (Oxford); 2006 Apr; 45(4):379-85. PubMed ID: 16418203
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies into the occurrence of soluble antigen-antibody complexes in disease. VII. Clinical-laboratory correlations of immunoglobulin complexes in rheumatoid synovial fluid.
    Russell ML; Gordon DA; BRoder I
    J Rheumatol; 1974 Jun; 1(2):153-8. PubMed ID: 4477197
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immune complex and rheumatoid arthritis].
    Kasukawa R
    Ryumachi; 1994 Apr; 34(2):175-6. PubMed ID: 8202835
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis.
    Bos WH; van de Stadt LA; Sohrabian A; Rönnelid J; van Schaardenburg D
    Arthritis Res Ther; 2014; 16(2):405. PubMed ID: 25167340
    [No Abstract]   [Full Text] [Related]  

  • 12. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.
    Bonagura VR; Artandi SE; Davidson A; Randen I; Agostino N; Thompson K; Natvig JB; Morrison SL
    J Immunol; 1993 Oct; 151(7):3840-52. PubMed ID: 7690818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis.
    Bokarewa M; Lindblad S; Bokarew D; Tarkowski A
    Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of rheumatoid arthritis.
    Ziff M
    Fed Proc; 1973 Feb; 32(2):131-3. PubMed ID: 4569690
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune reactions and rheumatoid arthritis.
    Fehr K
    Eur J Rheumatol Inflamm; 1982; 5(4):439-56. PubMed ID: 6983963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immobilized IgG-aggregate-induced cytolytic activity of lymphocytes from patients with rheumatoid arthritis.
    Fuson EW; Whittaker RL; Beard MR
    J Clin Lab Immunol; 1984 Dec; 15(4):181-6. PubMed ID: 6241257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune complex as a pathogenetic factor in rheumatoid arthritis].
    Munthe E
    Nord Med; 1971 Apr; 85(17):546. PubMed ID: 5089737
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis.
    György B; Tóthfalusi L; Nagy G; Pásztói M; Géher P; Lörinc Z; Polgár A; Rojkovich B; Ujfalussy I; Poór G; Pócza P; Wiener Z; Misják P; Koncz A; Falus A; Buzás EI
    Arthritis Res Ther; 2008; 10(5):R110. PubMed ID: 18789149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration.
    Winchester RJ; Kunkel HG; Agnello V
    J Exp Med; 1971 Sep; 134(3 Pt 2):286s-295s. PubMed ID: 4998932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.